Skip to main content

Reach α-synuclein-dependent neurodegeneration: clinical development of therapeutic AFFITOPE vaccines for Parkinson’s disease and multisystem atrophy

Publications

Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies.

Auteurs: Katja Kühbach; Judith Fabig; Christian Zafiu; Tuyen Bujnicki; Yvonne Herrmann; Andreas Kulawik; Johannes Willbold; Luriano Peters; Oliver Bannach; Oliver Bannach; Dieter Willbold; Dieter Willbold
Publié dans: Elsevier BV 2017
Identifiant permanent: Digital Object Identifier:10.1016/j.cca.2017.01.010

A Phase 1 Randomized Trial of Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy

Auteurs: MEISSNER, Wassilios; TRAON, A. P.; SAMIER FOUBERT, Alexandra; GALABOVA, G.; GALITZKY, M.; KUTZELNIGG, A.; LAURENS, B.; LUHRS, P.; MEDORI, R.; PERAN, P.; SABATINI, U.; VERGNET, S.; VOLC, D.; POEWE, W.; SCHNEEBERGER, A.; STAFFLER, G.; RASCOL, O.; INVESTIGATORS, A. F. F. Study
Publié dans: Wiley Movement Disorders 2020
Identifiant permanent: Digital Object Identifier:10.1002/mds.28218; PubMed Central ID:PMC7754431; PubMed ID:32882100